Thirumalai Chemicals Limited — Others, 08-07-2025: Copy of Newspaper Publication

Thirumalai Chemicals Limited has announced a board meeting to consider a preferential issue aimed at raising ₹450.62 Cr. The net proceeds will be primarily deployed for capital expenditure via investment in TCL Global B.V., which will further invest into TCL Specialties LLC in the USA, and for general corporate purposes, including ongoing expenses and investments in subsidiaries or joint ventures. The issue price is fixed at ₹270.94 per equity share based on an independent valuation. Corrections have been made to earlier disclosures regarding shareholding details and the use of proceeds, removing references to inorganic growth and acquisition activities. The company is conducting the Extraordinary General Meeting through video conferencing.